These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18245560)
1. PKCbeta modulates ischemia-reperfusion injury in the heart. Kong L; Andrassy M; Chang JS; Huang C; Asai T; Szabolcs MJ; Homma S; Liu R; Zou YS; Leitges M; Yan SD; Ramasamy R; Schmidt AM; Yan SF Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1862-70. PubMed ID: 18245560 [TBL] [Abstract][Full Text] [Related]
2. RAGE modulates myocardial injury consequent to LAD infarction via impact on JNK and STAT signaling in a murine model. Aleshin A; Ananthakrishnan R; Li Q; Rosario R; Lu Y; Qu W; Song F; Bakr S; Szabolcs M; D'Agati V; Liu R; Homma S; Schmidt AM; Yan SF; Ramasamy R Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1823-32. PubMed ID: 18245563 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling. Liu Y; Jin J; Qiao S; Lei S; Liao S; Ge ZD; Li H; Wong GT; Irwin MG; Xia Z Clin Sci (Lond); 2015 Aug; 129(4):331-44. PubMed ID: 25849791 [TBL] [Abstract][Full Text] [Related]
4. Y4 RNA fragments from cardiosphere-derived cells ameliorate diabetic myocardial ischemia‒reperfusion injury by inhibiting protein kinase C β-mediated macrophage polarization. Liu DZ; Luo XZ; Lu CH; Feng YY; Chen DX; Zeng ZY; Huang F Cardiovasc Diabetol; 2024 Jun; 23(1):202. PubMed ID: 38867293 [TBL] [Abstract][Full Text] [Related]
5. Central role of PKCbeta in neointimal expansion triggered by acute arterial injury. Andrassy M; Belov D; Harja E; Zou YS; Leitges M; Katus HA; Nawroth PP; Yan SD; Schmidt AM; Yan SF Circ Res; 2005 Mar; 96(4):476-83. PubMed ID: 15662033 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach. Liu Q; Chen X; Macdonnell SM; Kranias EG; Lorenz JN; Leitges M; Houser SR; Molkentin JD Circ Res; 2009 Jul; 105(2):194-200. PubMed ID: 19556521 [TBL] [Abstract][Full Text] [Related]
7. Acute rosiglitazone treatment is cardioprotective against ischemia-reperfusion injury by modulating AMPK, Akt, and JNK signaling in nondiabetic mice. Morrison A; Yan X; Tong C; Li J Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H895-902. PubMed ID: 21666107 [TBL] [Abstract][Full Text] [Related]
10. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism. Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832 [TBL] [Abstract][Full Text] [Related]
11. PKCbeta regulates ischemia/reperfusion injury in the lung. Fujita T; Asai T; Andrassy M; Stern DM; Pinsky DJ; Zou YS; Okada M; Naka Y; Schmidt AM; Yan SF J Clin Invest; 2004 Jun; 113(11):1615-23. PubMed ID: 15173888 [TBL] [Abstract][Full Text] [Related]
12. Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes. Fang J; Wei Z; Zheng D; Ying T; Hong H; Hu D; Lin Y; Jiang X; Wu L; Lan T; Yang Z; Zhou X; Chen L J Am Heart Assoc; 2020 Jul; 9(13):e016047. PubMed ID: 32567476 [TBL] [Abstract][Full Text] [Related]
13. Activation of RISK and SAFE pathways is not involved in the effects of Cx43 deficiency on tolerance to ischemia-reperfusion injury and preconditioning protection. Sánchez JA; Rodríguez-Sinovas A; Barba I; Miró-Casas E; Fernández-Sanz C; Ruiz-Meana M; Alburquerque-Béjar JJ; García-Dorado D Basic Res Cardiol; 2013 May; 108(3):351. PubMed ID: 23595215 [TBL] [Abstract][Full Text] [Related]
14. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury. de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1. Sicard P; Jacquet S; Kobayashi KS; Flavell RA; Marber MS Cardiovasc Res; 2009 Jul; 83(2):277-84. PubMed ID: 19213760 [TBL] [Abstract][Full Text] [Related]
16. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury. Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692 [TBL] [Abstract][Full Text] [Related]
17. Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis. Harja E; Chang JS; Lu Y; Leitges M; Zou YS; Schmidt AM; Yan SF FASEB J; 2009 Apr; 23(4):1081-91. PubMed ID: 19036858 [TBL] [Abstract][Full Text] [Related]
18. Calcium activated potassium channel and protein kinase C participate in the cardiac protection of remote post conditioning. Gao Q; Hu J; Hu J; Yu Y; Ye H; Li Z; Guan S Pak J Pharm Sci; 2013 Mar; 26(2):285-90. PubMed ID: 23455198 [TBL] [Abstract][Full Text] [Related]
19. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits. Rao Y; Wang YL; Zhang WS; Liu J Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844 [TBL] [Abstract][Full Text] [Related]
20. Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes. Gundewar S; Calvert JW; Elrod JW; Lefer DJ Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2462-71. PubMed ID: 17630348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]